# Abbott Laboratories: Form 8-K, filed Oct 18, 2023

- Company: [Abbott Laboratories](/companies/abt.md) (CIK 1800)
- Form: 8-K
- Filed: 2023-10-18
- Accepted by EDGAR: Oct 18, 2023, 11:37 ET
- Period: 2023-10-18
- Accession: 0001628280-23-034544
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1800/000162828023034544/abt-20231018.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1800/000162828023034544/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1800/000162828023034544/abt-20231018.htm

Filed Oct 18, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-034544. Last ingested by Listed: Oct 24, 2026, 14:50 ET. No prices; not investment advice.